Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
|
|
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 15.4% stake in MADRIGAL PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 9% stake in MADRIGAL PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 1.2% stake in MADRIGAL PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Deep Track Capital, LP reports a 0% stake in Madrigal Pharmaceuticals, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Madrigal Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 8.3% stake in Madrigal Pharmaceuticals, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.6% stake in Madrigal Pharmaceuticals Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/09/2021 |
SC 13G/A
| Capital Research Global Investors reports a 2.8% stake in Madrigal Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 9.7% stake in Madrigal Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Capital Research Global Investors reports a 10.8% stake in Madrigal Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2013 |
SC 13G/A
| FMR LLC reports a 3% stake in SYNTA PHARMACEUTICALS CORP |
| 02/14/2013 |
SC 13G/A
| FMR LLC reports a 10.5% stake in SYNTA PHARMACEUTICALS CORP |
| 02/14/2013 |
SC 13G/A
| Bahcall Safi R reports a 4.4% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/14/2013 |
SC 13G/A
| Chen Lan Bo reports a 3.9% stake in SYNTA PHARMACEUTICALS CORP. |
| 08/08/2012 |
SC 13G/A
| BlackRock Inc. reports a 5% stake in SYNTA PHARMACEUTICALS CORP |
| 02/14/2012 |
SC 13G/A
| SYNTA PHARMACEUTICALS CORP reports a 5.6% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2011 |
SC 13G/A
| SYNTA PHARMACEUTICALS CORP reports a 6.4% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/14/2011 |
SC 13G/A
| SYNTA PHARMACEUTICALS CORP reports a 8% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/12/2010 |
SC 13G/A
| SYNTA PHARMACEUTICALS CORP reports a 10% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/12/2010 |
SC 13G/A
| SYNTA PHARMACEUTICALS CORP reports a 7.3% stake in SYNTA PHARMACEUTICALS CORP. |
| 02/13/2009 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2009 |
SC 13G/A
| Chen Lan Bo reports a 10.1% stake in SYNTA PHARMACEUTICALS CORP. |
|
|